Dexamethasone, cisplatin, doxorubicin, cyclophosphamide and etoposide (DPACE) is an effective salvage regimen for multiple myeloma refractory to novel agents

被引:9
作者
Ronchetti, Anne-Marie [1 ]
Isnard, Francoise [1 ]
Et, Marc Buff [1 ]
Coman, Tereza [1 ]
Gorin, Norbert-Claude [1 ]
Coppo, Paul [1 ]
Garderet, Laurent [1 ]
Malak, Sandra [1 ]
机构
[1] Univ Paris 06, AP HP St Antoine, Dept Hematol, Paris, France
关键词
THALIDOMIDE; SURVIVAL;
D O I
10.3109/10428194.2012.733879
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:1117 / 1119
页数:3
相关论文
共 10 条
[1]   Guidelines for the diagnosis and management of multiple myeloma 2011 [J].
Bird, Jennifer M. ;
Owen, Roger G. ;
D'Sa, Shirley ;
Snowden, John A. ;
Pratt, Guy ;
Ashcroft, John ;
Yong, Kwee ;
Cook, Gordon ;
Feyler, Sylvia ;
Davies, Faith ;
Morgan, Gareth ;
Cavenagh, Jamie ;
Low, Eric ;
Behrens, Judith .
BRITISH JOURNAL OF HAEMATOLOGY, 2011, 154 (01) :32-75
[2]   Bendamustine, Thalidomide and Dexamethasone is an effective salvage regimen for advanced stage multiple myeloma [J].
Grey-Davies, Elisabeth ;
Bosworth, Jennifer L. ;
Boyd, Kevin D. ;
Ebdon, Caroline ;
Saso, Radovan ;
Chitnavis, Dipti ;
Mercieca, Jane E. ;
Morgan, Gareth J. ;
Davies, Faith E. .
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (04) :552-555
[3]   Genomic stratification of multiple myeloma treated with novel agents [J].
Jiang, Allan ;
Reece, Donna ;
Chang, Hong .
LEUKEMIA & LYMPHOMA, 2012, 53 (02) :202-207
[4]   Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: A multicenter international myeloma working group study [J].
Kumar, S. K. ;
Lee, J. H. ;
Lahuerta, J. J. ;
Morgan, G. ;
Richardson, P. G. ;
Crowley, J. ;
Haessler, J. ;
Feather, J. ;
Hoering, A. ;
Moreau, P. ;
LeLeu, X. ;
Hulin, C. ;
Klein, S. K. ;
Sonneveld, P. ;
Siegel, D. ;
Blade, J. ;
Goldschmidt, H. ;
Jagannath, S. ;
Miguel, J. S. ;
Orlowski, R. ;
Palumbo, A. ;
Sezer, O. ;
Rajkumar, S. V. ;
Durie, B. G. M. .
LEUKEMIA, 2012, 26 (01) :149-157
[5]   Improved survival in multiple myeloma and the impact of novel therapies [J].
Kumar, Shaji K. ;
Rajkumar, S. Vincent ;
Dispenzieri, Angela ;
Lacy, Martha Q. ;
Hayman, Suzanne R. ;
Buadi, Francis K. ;
Zeldenrust, Steven R. ;
Dingli, David ;
Russell, Stephen J. ;
Lust, John A. ;
Greipp, Philip R. ;
Kyle, Robert A. ;
Gertz, Morie A. .
BLOOD, 2008, 111 (05) :2516-2520
[6]   DCEP (dexamethasone, cyclophosphamide, etoposide, and cisplatin) is an effective regimen for peripheral blood stem cell collection in multiple myeloma [J].
Lazzarino, M ;
Corso, A ;
Barbarano, L ;
Alessandrino, E ;
Cairoli, R ;
Pinotti, G ;
Ucci, G ;
Uziel, L ;
Rodeghiero, F ;
Fava, S ;
Ferrari, D ;
Fiumanò, M ;
Frigerio, G ;
Isa, L ;
Luraschi, A ;
Montanara, S ;
Morandi, S ;
Perego, D ;
Santagostino, A ;
Savarè, M ;
Vismara, A ;
Morra, E .
BONE MARROW TRANSPLANTATION, 2001, 28 (09) :835-839
[7]   DTPACE: An effective, novel combination chemotherapy with thalidomide for previously treated patients with myeloma [J].
Lee, CK ;
Barlogie, B ;
Munshi, N ;
Zangari, M ;
Fassas, A ;
Jacobson, J ;
van Rhee, F ;
Cottler-Fox, M ;
Muwalla, F ;
Tricot, G .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2732-2739
[8]   Treatment Options for Relapsed and Refractory Multiple Myeloma [J].
Lonial, Sagar ;
Mitsiades, Constantine S. ;
Richardson, Paul G. .
CLINICAL CANCER RESEARCH, 2011, 17 (06) :1264-1277
[9]   Treatment of relapsed and refractory myeloma [J].
Reece, Donna E. ;
Leitch, Heather A. ;
Atkins, Harold ;
Voralia, Michael ;
Canning, Leah A. ;
LeBlanc, Richard ;
Belch, Andrew R. ;
White, Darrell ;
Kovacs, Michael J. .
LEUKEMIA & LYMPHOMA, 2008, 49 (08) :1470-1485
[10]   Survival and outcome of blastoid variant myeloma following treatment with the novel thalidomide containing regime DT-PACE [J].
Srikanth, Muralikrishnan ;
Davies, Faith E. ;
Wu, Ping ;
Jenner, Matthew W. ;
Ethell, Mark E. ;
Potter, Michael N. ;
Shaw, Bronwen E. ;
Saso, Radovan M. ;
Dines, Sharon ;
Morgan, Gareth J. .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2008, 81 (06) :432-436